Nevro (NVRO)
(Delayed Data from NYSE)
$5.10 USD
+0.39 (8.28%)
Updated Sep 12, 2024 04:00 PM ET
3-Hold of 5 3
D Value B Growth A Momentum C VGM
Industry / Sector Report
Industry : Medical - Instruments
Zacks Industry Rank
Top 25% (63 out of 251)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 3.50 | 1.66 | 9.99 |
Current Quarter Estimate | -0.82 | 4.85 | 61.00 |
Year Ago Quarter Estimate | -0.65 | 3.52 | 54.84 |
Next Quarter Estimate | -0.69 | 5.66 | 63.00 |
Next Year Estimate | -2.71 | 24.57 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -9.35 | 12.60 | 15.67 |
Next Year | -0.74 | 21.10 | 11.34 |
Last 5 Years | -294.60 | 10.20 | 8.10 |
Next 5 Years | 18.60 | 13.60 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | 7.55 |
Price/Book (MRQ) | 0.68 | 2.30 |
Price/Cash Flow (MRFY) | NA | 18.62 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -18.18% | -28.30% |
Return on Equity (TTM) | -24.89% | -24.58% |
Debt to Equity (MRQ) | 0.66 | 7.85 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.